AnnSofie Sternas - Karolinska Development Vice President IPR
KDEV Stock | SEK 1.52 0.02 1.30% |
President
Ms. AnnSofie Sternas was Vice President IPR at Karolinska Development AB since June 2012. She is European Patent Attorney and holds MS in Chemical Engineering. AnnSofie Sternas has almost 20 years of IP experience from large pharmaceutical companies and has held senior IPR positions within Astra and AstraZeneca. During many years AnnSofie was heavily involved in IP litigation of several blockbuster drugs. AnnSofie is specialized in IPstrategic matters with a heavy focus on the US legislation particularly IP in the interface between patent law and regulatory law. She is also part of a number of management teams within the Karolinska Development portfolio companies. since 2012.
Age | 53 |
Tenure | 12 years |
Phone | 46 8 52 48 60 70 |
Web | https://www.karolinskadevelopment.com |
Karolinska Development Management Efficiency
The company has return on total asset (ROA) of (0.0168) % which means that it has lost $0.0168 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1059) %, meaning that it generated substantial loss on money invested by shareholders. Karolinska Development's management efficiency ratios could be used to measure how well Karolinska Development manages its routine affairs as well as how well it operates its assets and liabilities. Karolinska Development AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. Karolinska Development AB was founded in 2003 and is headquartered in Stockholm, Sweden. Karolinska Development operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 7 people. Karolinska Development AB (KDEV) is traded on Stockholm Exchange in Sweden and employs 7 people.Management Performance
Return On Equity | -0.11 | |||
Return On Asset | -0.0168 |
Karolinska Development Leadership Team
Elected by the shareholders, the Karolinska Development's board of directors comprises two types of representatives: Karolinska Development inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Karolinska. The board's role is to monitor Karolinska Development's management team and ensure that shareholders' interests are well served. Karolinska Development's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Karolinska Development's outside directors are responsible for providing unbiased perspectives on the board's policies.
Hans Wigzell, Independent Chairman of the Board | ||
Elisabet Gimbringer, Controller | ||
Carl Sundberg, Director | ||
Magnus Persson, Director | ||
Jim Heusden, CEO | ||
Maria Ferm, Executive Assistant | ||
HansOlov Olsson, Director | ||
Theresa Tse, Director | ||
Viktor Drvota, Chief Investment Officer | ||
Esther Simo, Analyst | ||
John MD, Chief Partner | ||
Eva Montgomerie, Head of Accounting | ||
Michael Owens, Controller | ||
Yan Cheng, President Asia | ||
Ulf Richenberg, General Counsel | ||
Niclas Adler, Director | ||
Tse Ping, Director | ||
Christian Tange, CFO | ||
Daniel Bolanowski, Business Analyst | ||
Per Aniansson, Investment Director | ||
Johan Dighed, Chief CEO | ||
Terje Kalland, Chief Scientific Officer | ||
Linda Spahiu, Investment Mang | ||
Vladimir Artamonov, Independent Director | ||
Felicia Rittemar, Analyst | ||
AnnSofie Sternas, Vice President IPR | ||
Anders Harfstrand, Director | ||
Bo Hansen, Chairman of the Board | ||
Viktor MD, Chief Officer | ||
Fredrik Jarrsten, CFO | ||
Khalid Islam, Director | ||
Gunilla Ekstrom, Vice President - Operations | ||
Hans Toll, Chief Officer | ||
Henrijette Richter, Director |
Karolinska Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Karolinska Development a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.11 | |||
Return On Asset | -0.0168 | |||
Operating Margin | (14.44) % | |||
Current Valuation | 247.24 M | |||
Shares Outstanding | 267.28 M | |||
Shares Owned By Insiders | 37.17 % | |||
Shares Owned By Institutions | 5.97 % | |||
Price To Earning | 7.42 X | |||
Price To Book | 0.37 X | |||
Price To Sales | 204.26 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Karolinska Development in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Karolinska Development's short interest history, or implied volatility extrapolated from Karolinska Development options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Karolinska Development AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Karolinska Stock analysis
When running Karolinska Development's price analysis, check to measure Karolinska Development's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Karolinska Development is operating at the current time. Most of Karolinska Development's value examination focuses on studying past and present price action to predict the probability of Karolinska Development's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Karolinska Development's price. Additionally, you may evaluate how the addition of Karolinska Development to your portfolios can decrease your overall portfolio volatility.
Stocks Directory Find actively traded stocks across global markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |